Regulation of specific spinal neurons regulating pain transmission via chimeric toxins

US10022450B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10022450-B2
Application numberUS-201615241221-A
CountryUS
Kind codeB2
Filing dateAug 19, 2016
Priority dateMar 8, 2013
Publication dateJul 17, 2018
Grant dateJul 17, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A chimeric toxin is disclosed comprising a peptide ligand specifically targeting neurons involved in pain processing; and a clostridial neurotoxin light chain, wherein the ligand is linked to the light chain. The methods of preparing such chimeric toxin and the method of using the chimeric toxin to regulate pain transmission are also disclosed.

First claim

Opening claim text (preview).

We claim: 1. A method for inhibiting pain transmission in a patient in need thereof, the method comprising the step of administering to said patient a formulation comprising an effective amount of a chimeric toxin of a chimeric toxin comprising (i) a peptide ligand specifically targeting neurons involved in pain processing, wherein the ligand is Substance P (SEQ ID NO:1); and (ii) a clostridial neurotoxin light chain, wherein the ligand is linked to the light chain to form a chimeric toxin, and wherein the chimeric toxin does not comprise a translocation domain. 2. The method of claim 1 , wherein the formulation is delivered into lumbar intrathecal puncture space. 3. The method of claim 2 , wherein the formulation is in a water based isotonic vehicle prepared freshly prior to the administration. 4. The method of claim 1 , wherein the effective amount is in the range of 5 to 10000 U typically delivered in a volume of 1 mL. 5. The method of claim 4 , wherein the effective amount is in the range of 0.005 to 1000 micrograms of the ligand. 6. The method of claim 5 , wherein the effective amount is 0.5 micrograms. 7. The method of claim 1 , wherein the pain arises from cutaneous injury and inflammation, musculoskeletal injury and inflammation, visceral inflammation or injury, peripheral nerve injury as caused by chemicals, metabolic disease, physical injury, and mixtures thereof.

Assignees

Inventors

Classifications

  • for hormones {(for neuromediators C07K14/70571)} · CPC title

  • Bontoxilysin (3.4.24.69), i.e. botulinum neurotoxin · CPC title

  • containing a fusion with a toxin, e.g. diphteria toxin · CPC title

  • containing a localisation/targetting motif · CPC title

  • {Tachykinins, e.g.} Eledoisins {, Substance P}; Related peptides · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10022450B2 cover?
A chimeric toxin is disclosed comprising a peptide ligand specifically targeting neurons involved in pain processing; and a clostridial neurotoxin light chain, wherein the ligand is linked to the light chain. The methods of preparing such chimeric toxin and the method of using the chimeric toxin to regulate pain transmission are also disclosed.
Who is the assignee on this patent?
Wisconsin Alumni Res Found, Univ California
What technology area does this patent fall under?
Primary CPC classification A61K47/62. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Jul 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).